Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study

Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study

Abstract Background The World Health Organization (WHO) has identified carbapenem-resistant Pseudomonas aeruginosa (CRPA) as one of the three critical priority pathogens. There is scarce literature evaluating the treatment outcomes in patients with CRPA infections treated with traditional non-carbap...

Full description

Saved in:
Bibliographic Details
Main Authors: Namareq F. Aldardeer, Hatun M. Labban, Raghad T. Alhuthil, Seham H. Aljahdali, Moataz H. Alharbi, Riham A. Alharbi, Mohammed I. Al Musawa, Abdulrahman A. Almalki, Thamer A. Almangour
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Infectious Diseases
Subjects:
Carbapenem
Resistance
Pseudomonas aeruginosa
Cephalosporins
Piperacillin/Tazobactam
Online Access:https://doi.org/10.1186/s12879-024-10365-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12879-024-10365-5

Similar Items